Novartis

Novartis was founded in 1996  and is now a leading global medicines company. The company uses digital technologies and innovative science to create transformative treatments in areas of medical need.The firm has rank among the world’s top companies investing in research and development, reaching almost 1 billion individuals around the world. The firm is based in Switzerland, employing over 125,000 professionals of over 140 nationalities, working around the world.

The firm has historically been aggressive in tackling illnesses on multiple fronts, including pharmaceuticals and vaccines. Noartis’ innovative Medicines segment develops and manufactures prescription drugs for cancer, blood pressure, and other popular ailments. The company also has a Sandoz segment that is one of the largest manufacturers of generic drugs in the world. 

Novartis’ is divided into two businesses: Novartis Pharmaceuticals and  Novartis Oncology. Both segments aim to research, develop, manufacture, and sell prescription medications within oncology, immunology and dermatology, cardio-metabolic, retina, respiratory, and neuroscience. The segment has also expanded to be involved in the development and commercialization of gene and cell therapies. 

Specialties of the company include: unique portfolio focuses and broad healthcare portfolio, Innovation, Research, Quality, innovative medicines, global leader in eye care, Cell & Gene Therapy, Sustainability, Data & Digital, and generic medicines and biosimilars.